Research ·
How to assess medical device clinical data before a partnership
Before using a clinical result in a commercial presentation, identify the product, patients and outcome it refers to. A useful review starts with these questions rather than the highlighted percentage.
Check that the study addresses your question
Start by comparing the product under consideration with the formulation actually studied. Ask which indication, population and conditions of use were included. Where there is a difference, ask how the data relate to the proposed device.
The European Medical Device Regulation requires a clinical evaluation suited to the device’s characteristics and intended purpose, updated throughout its life cycle. A single publication therefore does not represent the entire evaluation dossier. Source: MDR, Article 61 and Annex XIV.
Read the comparison before the result
A result needs its reference point. A change between the start and end of follow-up answers a different question from a difference between a device group and a comparator group.
For randomised trials, CONSORT reporting recommendations include descriptions of interventions, group allocation and trial conduct. They support transparent reporting; they are not a certification of product efficacy. Source: CONSORT 2025.
A reduction in a score is not a recovery rate. If the outcome measures symptom intensity, commercial wording should preserve that meaning. The time at which an effect is measured must also be distinguished from how long it lasts.
Ask the questions that affect interpretation
Prepare a short reading checklist for the discussion with the manufacturer:
- Which product and population were studied?
- What was the comparator, and how were the groups assigned?
- What primary outcome was planned, and when was it measured?
- How many participants were enrolled and then analysed?
- What results, uncertainties and adverse events were reported?
- What limitations and competing interests did the authors disclose?
CONSORT covers participant flow, results and their precision, and the reporting of adverse events. These details help readers look beyond the abstract. Source: CONSORT 2025 explanation and elaboration.
Turn the data into accurate wording
Before using a commercial statement, trace it back to the passage that supports it. Keep the indication, population and outcome where omitting them would change the meaning. Avoid turning a result in a specific population into a promise for every user.
For example, an outcome measuring nasal discomfort does not automatically establish a benefit across every manifestation of an allergy. This reading principle does not assess any particular product: it simply requires a claim to match the outcome studied. Our article on local physical action also distinguishes a formulation’s mechanism from its documented clinical benefits.
Organise outstanding questions before the partnership
Group the remaining questions into three areas: how the study relates to the product, interpretation of the results, and wording suitable for your materials. This helps scientific and regulatory teams conduct a focused review.
You can complement this approach with the documents to examine under the MDR. For a VITROBIO product, the partnership page explains how to start the discussion and clarify which documents can be shared for your project.